The role of growth factors and related agents in accelerating fracture healing.
Simpson
A H R W
AH
The Musculoskeletal Tissue Engineering Consortium, Room SU304, University of Edinburgh, Chancellors Building, 49 Little France Crescent, Edinburgh EH16 4SB, UK. hsimpson@staffmail.ed.ac.uk
Mills
L
L
Noble
B
B
D055396:Bone Morphogenetic Protein 2; D055419:Bone Morphogenetic Protein 7; D019485:Bone Morphogenetic Proteins / Q000627:therapeutic use; D005346:Fibroblast Growth Factors / Q000627:therapeutic use; D017102:Fracture Healing / Q000502:physiology*; D015316:Genetic Therapy / Q000379:methods; D019382:Human Growth Hormone / Q000627:therapeutic use; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000627:therapeutic use*; D010281:Parathyroid Hormone / Q000627:therapeutic use; D010982:Platelet-Derived Growth Factor / Q000627:therapeutic use; D013002:Somatomedins / Q000627:therapeutic use; D016212:Transforming Growth Factor beta / Q000627:therapeutic use; D042461:Vascular Endothelial Growth Factor A / Q000627:therapeutic use
C525718:BMP2 protein, human; C525819:BMP7 protein, human; D055396:Bone Morphogenetic Protein 2; D055419:Bone Morphogenetic Protein 7; D019485:Bone Morphogenetic Proteins; D036341:Intercellular Signaling Peptides and Proteins; D010281:Parathyroid Hormone; D010982:Platelet-Derived Growth Factor; D013002:Somatomedins; D016212:Transforming Growth Factor beta; D042461:Vascular Endothelial Growth Factor A; D019382:Human Growth Hormone; D005346:Fibroblast Growth Factors